Astrocytes in heavy metal neurotoxicity and neurodegeneration
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
With the industrial development and progressive increase in environmental pollution, the mankind overexposure to heavy metals emerges as a pressing public health issue. Excessive intake of heavy metals, such as arsenic (As), manganese (Mn), mercury (Hg), aluminium (Al), lead (Pb), nickel (Ni), bismuth (Bi), cadmium (Cd), copper (Cu), zinc (Zn), and iron (Fe), is neurotoxic and it promotes neurodegeneration. Astrocytes are primary homeostatic cells in the central nervous system. They protect neurons against all types of insults, in particular by accumulating heavy metals. However, this makes astrocytes the main target for heavy metals neurotoxicity. Intake of heavy metals affects astroglial homeostatic and neuroprotective cascades including glutamate/GABA-glutamine shuttle, antioxidative machinery and energy metabolism. Deficits in these astroglial pathways facilitate or even instigate neurodegeneration. In this review, we provide a concise outlook on heavy metal-induced astroglio-pathies and their association with major neurodegenerative disorders. In particular, we focus on astroglial mechanisms of iron-induced neurotoxicity. Iron deposits in the brain are detected in main neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis. Accumulation of iron in the brain is associated with motor and cognitive impairments and iron-induced histopathological manifestations may be considered as the potential diagnostic biomarker of neurodegenerative diseases. Effective management of heavy metal neurotoxicity can be regarded as a potential strategy to prevent or retard neurodegenerative pathologies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Danbolt, N. C. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00067-8 · Cited by 4,227
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110 · cited 1×
“iron deposition is also increased in astrocytes from the cortex, hippocampus and basal ganglia (Farrall and Wardlaw, 2009; Block et al., 2007).”
BackgroundThe Role of Oxidative Stress in Parkinson's Disease
Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845
Verkhratsky, A., & Nedergaard, M. (2018) · Physiological Reviews · doi:10.1152/physrev.00042.2016 · Cited by 1,678 · cited 1×
“This transport is mediated by sodium-coupled neutral amino acid transporters; astroglial SNAT3/SLC38A3 and SNAT5/SLC38A5 mediate export of glutamine, while neuronal SNAT1/SLC38A1, SNAT2/SLC38A2 and SNAT4/SLC38A4 are responsible for glutamine import (Verkhratsky and Nedergaard, 2018; Verkhratsky and Rose, 2020).”
BackgroundSelf-citationMemory and Executive Function in Aging and AD
Buckner, R. L. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.006 · Cited by 1,508
Bak, L. K., Schousboe, A., & Waagepetersen, H. S. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03913.x · Cited by 1,114
Blood–brain barrier: Ageing and microvascular disease – systematic review and meta-analysis
Farrall, A. J., & Wardlaw, J. M. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.07.015 · Cited by 882
Identification of an Intestinal Heme Transporter
Shayeghi, M., Latunde-Dada, G. O., Oakhill, J. S., Laftah, A. H., Takeuchi, K., Halliday, N., Khan, Y., Warley, A., McCann, F. E., Hider, R. C., et al. (2005) · Cell · doi:10.1016/j.cell.2005.06.025 · Cited by 755 · cited 2×
“The heme iron absorption proceeds through the uptake of the heme carrier protein 1 (HCP-1) (Shayeghi et al., 2005; Krishnamurthy et al., 2007), while the export of the intracellular iron occurs through the ferroportin1 (Fpn1) (Troadec et al., 2010).”
BackgroundKuchibhotla, K. V., Goldman, S. T., Lattarulo, C. R., Wu, H.-Y., Hyman, B. T., & Bacskai, B. J. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.008 · Cited by 614
Iron metabolism in the CNS: implications for neurodegenerative diseases
Rouault, T. A. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3453 · Cited by 496 · cited 2×
“, 2019), because expression of iron transporters varies greatly in neural cells from different parts of the brain (Rouault, 2013).”
BackgroundUrrutia, P., Aguirre, P., Esparza, A., Tapia, V., Mena, N. P., Arredondo, M., González‐Billault, C., & Núñez, M. T. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12244 · Cited by 364
Streit, W. J., Xue, Q.-S., Tischer, J., & Bechmann, I. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0142-6 · Cited by 317 · cited 1×
“Ferritin positive dystrophic microglia are associated with β-amyloid plaques and neuofibrillary tangles (Streit et al. 2014).”
BackgroundHeme oxygenase-1 and neurodegeneration: expanding frontiers of engagement
Schipper, H. M., Song, W., Zukor, H., Hascalovici, J. R., & Zeligman, D. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06160.x · Cited by 298 · cited 1×
“However, iron overloaded astrocytes may become a trigger of neurotoxicity that contributes to the pathogenesis of age-dependent neurodegeneration, which involves iron-induced oxidative stress and mitochondrial malfunction (Dringen et al., 2007; Schipper et al., 2009).”
BackgroundAstroglial cradle in the life of the synapse
Verkhratsky, A., & Nedergaard, M. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0595 · Cited by 266
Self-citationLopes, K. O., Sparks, D. L., & Streit, W. J. (2008) · Glia · doi:10.1002/glia.20678 · Cited by 262 · cited 1×
“Accumulation of iron in microglia gradually increases with age through the elevation of ferritin (Lopes et al., 2008).”
BackgroundOxidative DNA damage and nucleotide excision repair
Melis, J. P. M., van Steeg, H., & Luijten, M. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5036 · Cited by 234
Astrocyte glutamine synthetase: pivotal in health and disease
Rose, C. F., Verkhratsky, A., & Parpura, V. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130237 · Cited by 224
Self-citationNon-transferrin-bound iron transporters
Knutson, M. D. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.10.413 · Cited by 221 · cited 1×
“Compared with the peripheral tissues, the concentration of non-transferrin-bound iron (NTBI) is higher in the CSF and interstitial fluid (IF), because citrate and ascorbate secreted by astrocytes help to maintain iron in the reduced Fe2+ status (Knutson, 2019; Ji and Kosman, 2015).”
BackgroundExpression of the iron transporter ferroportin in synaptic vesicles and the blood-brain barrier
Wu, L. J.-C., Leenders, A. G. M., Cooperman, S., Meyron-Holtz, E., Smith, S., Land, W., Tsai, R. Y. L., Berger, U. V., Sheng, Z.-H., & Rouault, T. A. (2004) · Brain Research · doi:10.1016/j.brainres.2003.10.066 · Cited by 210
The pivotal role of astrocytes in the metabolism of iron in the brain
Dringen, R., Bishop, G. M., Koeppe, M., Dang, T. N., & Robinson, S. R. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9375-0 · Cited by 209 · cited 10×
“After Fe2+ comes into the circulation, it is oxidized to Fe3+ by the ferroxidases including hephaestin (HEPH) and ceruloplasmin (CP); Fe3+ is transported by binding to transferrin (Tf) (Chen et al., 2004; Hellman and Gitlin, 2002).”
BackgroundInfluentialMandel, S., Amit, T., Bar-Am, O., & Youdim, M. B. H. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.06.001 · Cited by 164 · cited 2×
“Recent and growing evidence reports that disturbed iron homeostasis is an early presentation in the AD (Kim et al., 2018; Mandel et al., 2007), while the level of iron in the hippocampus and cortex of AD-patients is increased compared with healthy subjects (Corrigan et al.”
BackgroundResultGene-environment interactions in Alzheimer's disease: A potential path to precision medicine
Eid, A., Mhatre, I., & Richardson, J. R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.03.005 · Cited by 164 · cited 1×
“, 2015; Buckner, 2004), which results from integration of multiple factors, including genetic background, adverse lifestyle and environmental pressures (Eid et al., 2019).”
BackgroundAndersen, H. H., Johnsen, K. B., & Moos, T. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1509-8 · Cited by 151 · cited 1×
“Accumulation of iron in microglia is consistently observed in the neurodegeneration-prone brain regions, providing a high correlation between the pathological phenomena of neurodegeneration and the increase of iron in microglia (Andersen et al. 2014).”
BackgroundWang, J., Song, N., Jiang, H., Wang, J., & Xie, J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.01.021 · Cited by 150 · cited 1×
“Aberrant iron homeostasis increases the release of proinflammatory cytokines from microglia in vitro (Wang et al. 2013).”
BackgroundXia, M., Yang, L., Sun, G., Qi, S., & Li, B. (2017) · Psychopharmacology · doi:10.1007/s00213-016-4473-9 · Cited by 149 · cited 2×
“Mechanism of depression as a risk factor in the development of Alzheimer’s disease: the function of AQP4 and the glymphatic system.”
BackgroundSelf-citationLevi, S., & Tiranti, V. (2019) · Pharmaceuticals · doi:10.3390/ph12010027 · Cited by 90 · cited 1×
“Abnormally increased iron in the brain of AD patients can interact with H2O2 to produce highly active hydroxyl radicals, which damage cellular structures (Levi and Tiranti, 2019).”
BackgroundIroning out cell death mechanisms
Reed, J. C., & Pellecchia, M. (2012) · Cell · doi:10.1016/j.cell.2012.05.009 · Cited by 87
Nandar, W., Neely, E. B., Unger, E., & Connor, J. R. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.02.009 · Cited by 64 · cited 14×
“Zinc dyshomeostasis is associated with several neurological disorders including depression, schizophrenia, AD, ALS and ageingrelated cognitive decline (Levenson and Tassabehji, 2007; Grabrucker et al., 2011; Adlard et al., 2014).”
BackgroundInfluentialGlia and zinc in ageing and Alzheimer’s disease: a mechanism for cognitive decline?
Hancock, S. M., Finkelstein, D. I., & Adlard, P. A. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00137 · Cited by 42
Iron Aggravates the Depressive Phenotype of Stressed Mice by Compromising the Glymphatic System
Liang, S., Lu, Y., Li, Z., Li, S., Chen, B., Zhang, M., Chen, B., Ji, M., Gong, W., Xia, M., et al. (2020) · Neuroscience Bulletin · doi:10.1007/s12264-020-00539-x · Cited by 41 · cited 4×
“Injection of iron dextran further worsens the operation of the glymphatic system and exacerbates the depressive-like behaviours induced by CUMS; in turn, this triggers neuronal apoptosis (Liang et al., 2020).”
BackgroundResultSelf-citation
Cited by
Astrocytes in human central nervous system diseases: a frontier for new therapies
Verkhratsky, A., Butt, A., Li, B., Illes, P., Zorec, R., Semyanov, A., Tang, Y., & Sofroniew, M. V. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01628-9 · Cited by 428
Self-citationWu, Y.-S., Osman, A. I., Hosny, M., Elgarahy, A. M., Eltaweil, A. S., Rooney, D. W., Chen, Z., Rahim, N. S., Sekar, M., Gopinath, S. C. B., et al. (2024) · ACS Omega · doi:10.1021/acsomega.3c07047 · Cited by 420
Principles of Astrogliopathology
Verkhratsky, A., Li, B., Scuderi, C., & Parpura, V. (2021) · Advances in Neurobiology · doi:10.1007/978-3-030-77375-5_3 · Cited by 21
Self-citationInterlaminar and varicose-projection astrocytes: toward a new understanding of the primate brain
Ciani, C., & Falcone, C. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1477753 · Cited by 11
Metadata
- Authors
- Li, B., Xia, M., Zorec, R., Parpura, V., & Verkhratsky, A.
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 2021-02
- Volume
- 1752
- Pages
- 147234
- ISSN
- 0006-8993 (ISSN-L)
- OpenAlex
- W3119804279
- Cited by
- 165
- References
- 30
- FWCI
- 8.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.